Study:Many MDs won't see sales reps

A new study suggests that nearly one-fifth of office-based physicians refuse to see sales reps from the drug and device industry, and nearly 23 percent more won't see the reps unless they set an appointment. The survey data comes from a telephone survey of 180,000 office-based physicians in the U.S.

The study, by SK&A Information Services, concluded that of those who will see reps, 73 percent are open to seeing them pretty much anytime, while 5 percent of physicians will visit with industry reps only on specific days of the week, and 3.2 percent of physicians limit their time with reps to specific times of the day (most commonly lunch time). As with other white collar workers, Friday afternoons and Monday mornings are the hardest time to get their attention, the researchers noted.

To learn more about the study:
- read this SK&A press release

Related Articles:
DC considers pharma rep licenses, data mining limits. Report
DC passes pharma rep licensing rule. Report
Fight continues over state limits on prescription data mining. Report
Data providers challenge prescription-privacy laws. Report
NH bans prescription data collection by pharmas. Report
Pharmas protest NH drug info law. Report
Law would make pharmas reveal MD payments. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.